Malcolm D. Mason
Impact in
- Cancer Research top 0.2%
- MicroRNA in disease regulation
- Pulmonary and Respiratory Medicine top 0.1%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 67
- Prostate Cancer Diagnosis and Treatment 45
-
- Extracellular vesicles in disease 17
- Co-authors
- Aled Clayton (24 shared papers)Zsuzsanna Tabi (22 shared papers)Joaquim Bellmunt (10 shared papers)Nicolas Mottet (11 shared papers)Thomas Wiegel (10 shared papers)Theodorus van der Kwast (9 shared papers)Steven Joniau (8 shared papers)M. Bolla (7 shared papers)
- Journals
- Journal of Clinical Oncology (23 papers)British Journal of Urology (12 papers)Clinical Oncology (11 papers)European Journal of Cancer (10 papers)European Urology (9 papers)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Malcolm D. Mason
243 papers receiving 18.3k citations
Malcolm D. Mason's Hit Papers
Peers
Comparison fields: 5 of 168
- Cancer Research 3.6k
- Pulmonary and Respiratory Medicine 6.4k
- Oncology 2.9k
- Molecular Biology 6.3k
- Immunology 1.8k
Countries citing papers authored by Malcolm D. Mason
This map shows the geographic impact of Malcolm D. Mason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malcolm D. Mason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malcolm D. Mason more than expected).
Fields of papers citing papers by Malcolm D. Mason
This network shows the impact of papers produced by Malcolm D. Mason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malcolm D. Mason. The network helps show where Malcolm D. Mason may publish in the future.
Co-authors
The 25 scholars most cited alongside Malcolm D. Mason, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 249 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013 Hit paper breakdown → | 2013 | 1568 |
| 2 | EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease Hit paper breakdown → | 2010 | 1195 |
| 3 | EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer Hit paper breakdown → | 2016 | 1125 |
| 4 | Cancer Exosomes Trigger Fibroblast to Myofibroblast Differentiation Hit paper breakdown → | 2010 | 714 |
| 5 | 2001 | 487 | |
| 6 | 2008 | 467 | |
| 7 | 2011 | 460 | |
| 8 | 2007 | 442 | |
| 9 | EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer Hit paper breakdown → | 2011 | 393 |
| 10 | 2005 | 386 | |
| 11 | 2001 | 375 | |
| 12 | Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes Hit paper breakdown → | 2014 | 370 |
| 13 | 2010 | 353 | |
| 14 | 2003 | 333 | |
| 15 | 2003 | 303 | |
| 16 | 2014 | 288 | |
| 17 | 2005 | 282 | |
| 18 | 2004 | 278 | |
| 19 | Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data Hit paper breakdown → | 2015 | 267 |
| 20 | 2009 | 263 |
About Malcolm D. Mason
Malcolm D. Mason is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Surgery and Immunology, having authored 249 papers that have together received 18.8k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (67 papers), Prostate Cancer Diagnosis and Treatment (45 papers), Immunotherapy and Immune Responses (19 papers), Bladder and Urothelial Cancer Treatments (18 papers), Extracellular vesicles in disease (17 papers), Testicular diseases and treatments (14 papers), Radiopharmaceutical Chemistry and Applications (12 papers) and Cell Adhesion Molecules Research (9 papers). The work is most often cited by research in Cancer Research (3.6k citations), Pulmonary and Respiratory Medicine (6.4k citations), Oncology (2.9k citations), Molecular Biology (6.3k citations) and Immunology (1.8k citations). Malcolm D. Mason has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Aled Clayton, Zsuzsanna Tabi, Joaquim Bellmunt, Nicolas Mottet, Thomas Wiegel, Theodorus van der Kwast, Steven Joniau, M. Bolla, Jason Webber and Wen G. Jiang. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Urology, Clinical Oncology, European Journal of Cancer and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.